ERYTHROMYCIN ETHYLSUCCINATE
Active substance: erythromycin ethylsuccinate
SUSPENSION · ERYTHROMYCIN ETHYLSUCCINATE 400 mg/5mL
United StatesActive
Marketing holder: Wilshire Pharmaceuticals
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ERYTHROMYCIN ETHYLSUCCINATE · 400 mg/5mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-b813-7a21-b8cf-5867b144a196,01a1208c-c071-7893-8e5d-c9f0509e3d42,01a1208c-c6c0-7f1a-a1ec-c40a3a96cd59,01a1208d-3bb8-7907-8411-df9b75a10afe,01a1208d-eb2b-7ce0-a11b-bb40b58268f9;count=26 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 52536-130
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 52536-130 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 52536-130 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 52536-130 · Verified 2026-10-09 · open in source